Market revenue in 2023 | USD 37.9 million |
Market revenue in 2030 | USD 75.5 million |
Growth rate | 10.4% (CAGR from 2023 to 2030) |
Largest segment | Tandem mass spectrometry |
Fastest growing segment | Electrophoresis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
Key market players worldwide | Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp |
Tandem mass spectrometry was the largest segment with a revenue share of 24.8% in 2023. Horizon Databook has segmented the India newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.
With dense and growing population and rising prevalence of critical conditions, India is expected to provide great platform for growth of newborn screening market. The cost-conscious behavior of the people and comparatively low per capita health expenditure may hamper the market penetration in the country.
However, the strategic plans by focusing on the premier class and growing disposable incomes along with developing economy may help in growing the patient awareness level. Recent government initiatives by agencies such as Public Health Foundation are expected to change the market scenario for latest technology involved in the healthcare sector.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account